Bone marrow stromal cell interaction reduces syndecan-1 expression and induces kinomic changes in myeloma cells.
about
Multiple myeloma cancer stem cellsExtracellular vesicle cross-talk in the bone marrow microenvironment: implications in multiple myelomaMolecular resistance fingerprint of pemetrexed and platinum in a long-term survivor of mesotheliomaViolacein induces death of resistant leukaemia cells via kinome reprogramming, endoplasmic reticulum stress and Golgi apparatus collapseToll-like receptor 9, transmembrane activator and calcium-modulating cyclophilin ligand interactor, and CD40 synergize in causing B-cell activation.Cancer associated fibroblasts and tumor growth: focus on multiple myelomaInvestigating osteogenic differentiation in multiple myeloma using a novel 3D bone marrow niche model.CD138-negative myeloma cells regulate mechanical properties of bone marrow stromal cells through SDF-1/CXCR4/AKT signaling pathwayPhenotypic, genomic and functional characterization reveals no differences between CD138++ and CD138low subpopulations in multiple myeloma cell linesMitochondrial-Targeted Decyl-Triphenylphosphonium Enhances 2-Deoxy-D-Glucose Mediated Oxidative Stress and Clonogenic Killing of Multiple Myeloma CellsChimeric Antigen Receptor T Cells against CD19 for Multiple MyelomaMultiple myeloma cells expressing low levels of CD138 have an immature phenotype and reduced sensitivity to lenalidomide.Clonogenic multiple myeloma cells have shared stemness signature associated with patient survivalMultiple myeloma mesenchymal stem cells: characterization, origin, and tumor-promoting effects.Multiple myeloma-initiating cells.Hypoxia reduces CD138 expression and induces an immature and stem cell-like transcriptional program in myeloma cells.Bone marrow-derived mesenchymal stromal cells are attracted by multiple myeloma cell-produced chemokine CCL25 and favor myeloma cell growth in vitro and in vivo.Improved intra-array and interarray normalization of peptide microarray phosphorylation for phosphorylome and kinome profiling by rational selection of relevant spots.Characterization of potential CD138 negative myeloma "stem cells".Tumor-initiating capacity of CD138- and CD138+ tumor cells in the 5T33 multiple myeloma model.Mesenchymal stem cells in multiple myeloma: a therapeutical tool or target?
P2860
Q26752365-0B2F4A59-CF6C-4F02-A597-0021BAFB8A6FQ28077635-45FDB922-C962-45D0-8126-9BF9DD7B94DFQ28482133-AC8D74EC-87A1-4424-9C8D-56294C5F193EQ28484370-F2A1DD26-B4D3-4425-B653-76E00488613BQ30425171-7AE06DFB-CADC-4033-B84E-FD31A5F2FE97Q34309899-32AE2312-6511-4900-AC37-F4CBF7EF3967Q34551206-2DF38E57-9EB9-4FA8-A89A-2F3A7A81D934Q34898664-E02EFA56-8655-4188-9147-DF5E4B76996EQ35128148-E33C3F3F-349C-4020-A821-C420FD183139Q36208283-4AD26EA5-2D7F-4FE1-A670-70BDA4D76835Q36284584-1A9B6F59-42ED-4D68-99B9-9529E86D8199Q36640589-326B08B1-213F-4425-8758-84CA2D826F75Q37207661-2A3C307B-822C-49FE-A199-80DC206C343EQ37953844-F09C5021-6A23-43ED-8988-473763069811Q38082688-840D3068-313C-4714-83A3-8EC03EC566D4Q39078376-B98A9AB1-41D9-4421-AC80-442CD7D42E20Q39439676-B6587445-A3F0-4606-ACE8-5D254AE3ADDFQ41822444-9B1E9877-6D78-465B-938D-9E903CF30625Q42917504-8D514383-1E5A-46A9-8A77-4FDDA35A30A2Q43008917-202C8DE9-1B06-4C97-AA1A-BDD2B40F5E95Q55471455-B6D33A58-FB20-4B3D-BDE5-E7813549A3C7
P2860
Bone marrow stromal cell interaction reduces syndecan-1 expression and induces kinomic changes in myeloma cells.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Bone marrow stromal cell inter ...... omic changes in myeloma cells.
@en
Bone marrow stromal cell inter ...... omic changes in myeloma cells.
@nl
type
label
Bone marrow stromal cell inter ...... omic changes in myeloma cells.
@en
Bone marrow stromal cell inter ...... omic changes in myeloma cells.
@nl
prefLabel
Bone marrow stromal cell inter ...... omic changes in myeloma cells.
@en
Bone marrow stromal cell inter ...... omic changes in myeloma cells.
@nl
P2093
P1476
Bone marrow stromal cell inter ...... omic changes in myeloma cells.
@en
P2093
Anja Seckinger
Daniel Chesik
Gwenny M Fuhler
Mirjam Baanstra
Nico A Bos
Rajesh Somasundaram
P304
P356
10.1016/J.YEXCR.2010.03.013
P407
P577
2010-03-20T00:00:00Z